Jacobs Levy Equity Management
BLFS icon

Jacobs Levy Equity Management’s BioLife Solutions BLFS Stock Holding History

Jacobs Levy Equity Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
61,852
+50,753
+457% +$1.19M 0.01% 624
2026
Q1 		$212K Hold
11,099
– – ﹤0.01% 910
2025
Q4 		$268K Sell
11,099
-1,032
-9% -$27K ﹤0.01% 867
2025
Q3 		$309K Sell
12,131
-263
-2% -$6.24K ﹤0.01% 878
2025
Q2 		$267K Hold
12,394
– – ﹤0.01% 952
2025
Q1 		$283K Buy
+12,394
New +$326K ﹤0.01% 986

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jacobs Levy Equity Management's BLFS Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its BioLife Solutions (BLFS) stake by 457% in Q2 2026, buying an estimated $1.19M and bringing the position to 61,852 shares worth $1.75M. The position accounts for 0.01% of the portfolio, ranked #624.

Jacobs Levy Equity Management first reported a position in BLFS in Q1 2025 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Jacobs Levy Equity Management held 61,852 shares of BioLife Solutions worth $1.75M as of Q2 2026.
  • Jacobs Levy Equity Management bought 50,753 BioLife Solutions shares in Q2 2026, an estimated $1.19M.
  • BioLife Solutions made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #624 holding.
  • Jacobs Levy Equity Management first reported a position in BioLife Solutions in Q1 2025 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.